Inventor

OLIVIER JR KENNETH J

US2 patents

Patents

2 patents

US9226966B2Jan 5, 2016

Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

MERRIMACK PHARMACEUTICALS INC2 citations54

US9610249B2Apr 4, 2017

Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents

MERRIMACK PHARMACEUTICALS INC0 citations44